MSB 3.33% $1.40 mesoblast limited

Ann: MSB Named Global Technology Leader In Cell Therapy Industry, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 693 Posts.
    lightbulb Created with Sketch. 266
    BTW - have a look at the F&S website - this is an Australian award, by F&S Australia - not global.

    And it's one of 32 awards all in extremely narrow fields, eg Australia Hospital Asset Tracking Solutions Vendor of the Year, Australia Drone Solutions and Services Growth Excellence Leadership, Australia Customer Contact Optimisation Solutions Vendor of the Year and Australia Medical Billing & Practice Management (Secondary & Tertiary Care) Company of the Year.

    Narrow, tailored to individual clients by the look of it.

    In a proper award system you might expect to find several awards across multiple biotech fields.

    But no, only stem cells!! Smacks of Vanity Award to me - look at the full list for proof of that!
    Last edited by Techinvestor: 08/12/17
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.40
Change
0.045(3.33%)
Mkt cap ! $1.592B
Open High Low Value Volume
$1.35 $1.42 $1.33 $3.802M 2.753M

Buyers (Bids)

No. Vol. Price($)
2 23940 $1.39
 

Sellers (Offers)

Price($) Vol. No.
$1.40 22571 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.